Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
about
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer
@en
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer.
@nl
type
label
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer
@en
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer.
@nl
prefLabel
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer
@en
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer.
@nl
P2093
P2860
P921
P1433
P1476
Preclinical Efficacy and Safet ...... Conjugates for Ovarian Cancer
@en
P2093
Jingquan Li
Kerong Chen
Xiaoguang Li
Yanling Liu
P2860
P356
10.1016/J.EBIOM.2016.11.026
P577
2016-11-23T00:00:00Z